GSK’s £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks
The £45bn company that will be created from the demerger of GlaxoSmithKline’s (GSK) consumer products arm is in talks to hire a roster of investment bankers in one of the year’s most prestigious City pitches.Sky News has…